E08G0052 Canine Galectin 3 ELISA Kit
Canine Galectin 3 ELISA kit is suitable for the detection of samples from Canine species. Galectin 3 can also be called LGALS3, CBP35, GALBP, GALIG, MAC2, 35 kDa lectin, Carbohydrate-binding protein 35, Galactose-specific lectin 3, Galactoside-binding protein, Laminin-binding protein, Lectin L-29, GAL3.
Product Information | |
Cat. No. | E08G0052 |
Product Name | Canine Galectin 3 ELISA kit |
Species | Canine |
Product Size | 48 Tests / 96 Tests |
Concentration | 0.5-10 ng/mL |
Sensitivity | 0.1 ng/mL |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 ng/mL | 1 vial |
STANDARD B (0.5mL) | 0.5 ng/mL | 1 vial |
STANDARD C (0.5mL) | 1 ng/mL | 1 vial |
STANDARD D (0.5mL) | 2.5 ng/mL | 1 vial |
STANDARD E (0.5mL) | 5 ng/mL | 1 vial |
STANDARD F (0.5mL) | 10 ng/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
GAL3 ELISA kit applies the competitive enzyme immunoassay technique utilizing an anti-GAL3 antibody and an GAL3-HRP conjugate. The assay sample and buffer are incubated together with GAL3-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the GAL3 concentration since GAL3 from samples and GAL3-HRP conjugate compete for the anti-GAL3 antibody binding site. Since the number of sites is limited, as more sites are occupied by GAL3 from the sample, fewer sites are left to bind GAL3-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The GAL3 concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% ＜10% | |
Inter Variation% ＜12% | ||
Recovery | 91-105% | |
Linearity | Diluent Ratio | Range % |
1:2 | 87-108 | |
1:4 | 86-111 | |
1:8 | 83-113 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between GAL3 and analogues was observed. | |
E08G0052 has been referenced in the below publications:
Changes of cardiac function in diabetic dogs.
Galectin-3 in cardiac muscle and circulation of dogs with degenerative mitral valve disease.
Related Bluegene Biotech Products
BlueGene Biotech News
